Qu, J., Sun, W., Li, Y., Cai, Z., Wu, B., Shen, Q., . . . Zhou, J. Immune profiling identifies CD161+CD127+CD8+ T cells as a predictive biomarker for Anti-PD-L1 therapy response in the SCLC-I subtype. BMC.
Chicago Style (17th ed.) CitationQu, Jingjing, et al. Immune Profiling Identifies CD161+CD127+CD8+ T Cells as a Predictive Biomarker for Anti-PD-L1 Therapy Response in the SCLC-I Subtype. BMC.
MLA (9th ed.) CitationQu, Jingjing, et al. Immune Profiling Identifies CD161+CD127+CD8+ T Cells as a Predictive Biomarker for Anti-PD-L1 Therapy Response in the SCLC-I Subtype. BMC.
Warning: These citations may not always be 100% accurate.